In the News
Congratulations to Harrison Nguyen, Emory Dermatology first year resident who was the winner of the Donald C. Abele, MD Award for Outstanding Resident Presentation at this year's 64th Annual Meeting of the Georgia Society of Dermatology and Dermatologic Surgery!
Harrison's presentation was entitled, "Coke Is It?"
Thursday, October 17, 2019
Ken Anderson, MD, FISHR, ABHRS
Founder and Director
Anderson Center for Hair
"Hair Restoration Surgery: An Overview for 2019"
Thursday, November 21, 2019
Zachary W. Eyre, MD, MBA
Department of Dermatology
Thursday, December 5, 2019
"Coginitive-based Compassion Training"
** To be held in the Whitehead Auditorium
January 16, 2020
Welcome from the Chair
The Department of Dermatology at the Emory University School of Medicine plays important roles locally, regionally, nationally, and internationally. Our primary focus is on skin diseases and the patients affected by them. We look at the problems associated with skin disease from a variety of perspectives both local and global. While we care for individual patients and train learners one at a time, we also view discovery and training from a big picture viewpoint, examining molecular pathways driving skin disorders, skin diseases at population health levels, or perspectives on how to train a healthcare workforce to deal with skin diseases in populations of the future, here and abroad. More...
Propranolol Exhibits Activity Against Hemangiomas Independent of Beta Blockade
Maiko Sasaki, Paula E. North, Justin Elsey, Jeffrey Bubley, Shikha Rao, Yoonhee Jung, Shengnan Wu, Ming-Hui Zou, Brian P. Pollack, Jayanth Kumar, Hartej Singh, and Jack L. Arbiser
Crushed It: Elucidation of Systemic Vasculitis Caused by Injected Hydromorphone Tablets via Skin Biopsy.
Robin Rolader, Brian Bishop, Zachary W. Eyre, and Justin T. Cheeley
Triple Therapy with Intralesional 5-Fluorouracil, Chemowraps, and Acitretin: A Well-Tolerated Option for Treatment of Widespread Cutaneous Squamous Cell Carcinomas on the Legs
Iviensan F. Manalo, Michael C. Lowe, Kelly C. Nelson, and Suephy C. Chen
Timothy E. Holland and Salma de la Feld
Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression
Sanjay Chandrasekaran, Maiko Sasaki, Christopher D. Scharer, Haydn T. Kissick, Dillon G. Patterson, Kelly R. Magliocca, John T. Seykora, Bishu Sapkota, David A. Gutman, Lee A. Cooper, Gregory B. Lesinski, Edmund K. Waller, Susan N. Thomas, Sergei V. Kotenko, Jeremy M. Boss, Carlos S. Moreno, Robert A. Swerlick and Brian P. Pollack